Friday 23 December 2011

Canada: Healthcare System and Drug Regulatory Overview


The pricing and reimbursement process in Canada is considered to be challenging to pharma, and although the Patented Medicines Prices Review Board, the Common Drug Review, and the public drug plans have their distinct strategies for regulating drug prices, there is substantial variation in reimbursement between provinces.

In terms of the drug approval process, Health Canada takes longer to award marketing approval for new drugs than the European Medicines Agency (EMA). Consequently, in order to speed up the process, user fees were increased in April 2011, and from April 2012 all fees will be increased annually by 2%.

Canada lacks any workable right of appeal under its linkage system and it is the only G7 nation that does not offer any form of patent term restoration. Because of this, Canada is on the PhRMA Special 301 Watch List and major reform of the intellectual property system has been called for.

Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/144094-canada-healthcare-system-and-drug-regulatory-overview.html

Features and benefits
• Assess the key factors facing pharma in terms of regulatory issues, pricing and reimbursement.
• Review the insurance and healthcare system in Canada including recent health reforms.
• Gain insight into regulatory and intellectual property issues in Canada.
• Review important pricing and reimbursement issues in Canada.

The pricing and reimbursement process in Canada is considered to be challenging to pharma. Furthermore, Health Canada takes longer to award marketing approval for new drugs than the European Medicines Agency (EMA). Also, while the intellectual property environment in Canada has improved in recent years, it is still considered to be behind that of other G7 countries.

Explore Table of Contents available in the report Canada: Healthcare System and Drug Regulatory Overview.

Wednesday 21 December 2011

Market and Product Forecasts: COPD in China – Novel therapies to see patient potential limited by high cost


The increasing prevalence of COPD and new therapies will boost the Chinese COPD market from $204m to $317m by 2020. Spiriva will become the market leader from 2013 and maintain the position through 2020, owing to its wide application across all disease severities. A number of novel products will increase the product offering on the market, with most pipeline products aimed at more severe patients.

Request a Sample for or Inquire before buying the report @
http://www.reportsnreports.com/reports/144096-market-and-product-forecasts-copd-in-china-novel-therapies-to-see-patient-potential-limited-by-high-cost.html

Features and benefits
• Access Datamonitor’s patient-based COPD market forecast in China, with transparent methodology and clear assumptions.
• Explore the current and future market size of COPD in China and see which key brands will impact the market.
• Gain insight into COPD market dynamics, and see where untapped market potential remains.
• Understand which factors are driving growth in the Chinese COPD market, and what challenges pipeline products face.

Highlights
Datamonitor forecasts the Chinese COPD market to increase from $204m in 2011 to $317m by 2020, at a compound annual growth rate (CAGR) over 2011–20 of 5.0%. Market growth will not only be boosted by patients continuing to switch to more convenient, and more expensive, combination drugs, but also by the increasing prevalence of COPD in China.

Datamonitor forecasts that five new therapies will enter the Chinese market over 2011–20, including the first once-daily ICS/LABA combination and LABA/LAMA combinations. While these combinations are clinically attractive, their commercial potential will be restricted by their relatively high price.

Datamonitor estimates that in 2011 Seretide and Spiriva top all brands by achieving $48m and $46m respectively, together capturing 46% of the Chinese COPD market. Spiriva will face competition from several pipeline products after 2013, but its wide clinical application across all disease severities will allow it to maintain its market dominance.

Explore Table of Contents available in the report Market and Product Forecasts: COPD in China – Novel therapies to see patient potential limited by high cost

Wednesday 14 December 2011

Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017


GlobalData’s new report, “Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017” provides key data, information and analysis on the global insulin pumps market. The report provides market landscape, competitive landscape and market trends information on the insulin pumps market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market’s dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
• Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
• Key segments covered include Disposable Insulin Pumps and Traditional Insulin Pumps.
• Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.
• Qualitative analysis of key market trends, market drivers, and restraints within the insulin pumps market.
• The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
• Key players covered include Medtronic, Insulet Corporation, Animas Corporation and Roche.

Reasons to Buy
• Develop business strategies by understanding the trends and developments that are driving the insulin pumps globally.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
• What’s the next big thing in the insulin pumps market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global insulin pumps market and the factors shaping it.

Monday 12 December 2011

Peru Power Market Outlook to 2030 - Market Trends, Regulation and Competitive Landscape


This report includes a detailed analysis of the current investment climate in the country’s power sector and over the next decade across 6 broad parameters. Each parameter has a weight assigned, and a weighted average score is calculated to obtain the final country ranking in that region. The study also maps the relative ranking of the key countries in the region according to the current investment opportunities in the country and that by 2020. This report also examines the Peru Power Market  to 2030 structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the market’s regulatory structure, supply and demand balance, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided.

Scope
• Analysis of the current investment climate in the country’s power sector across six parameters and over the next decade
• Relative ranking of the key country’s in the region according to the current investment opportunities in the country and that by 2020.
• Statistics for installed capacity, power generation and consumption from 2000 to 2010, forecast forward 19 years to 2030
• Break-up by technology, including thermal, hydro, renewable and nuclear
• Data on key current and upcoming projects
• Information on grid interconnectivity, distribution losses and power exports and imports
• Policy and regulatory framework governing the market
• Detailed analysis of top market participant, including market share analysis and SWOT analysis
• Data sourced from proprietary databases and primary interviews with key participants across the value chain

Reasons to Buy
Peru Power Market Outlook to 2030 - Market Trends, Regulation and Competitive Landscape
• Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the country’s power sector
• Identification of key factors driving investment opportunities in the country’s power sector
• Facilitate decision-making based on strong historic and forecast data
• Develop strategies based on the latest regulatory events
• Position yourself to gain the maximum advantage of the industry’s growth potential
• Identify key partners and business development avenues
• Identify key strengths and weaknesses of important market participants
• Respond to your competitors’ business structure, strategy and prospects


Molecular Diagnostics: Market Landscape


This report Molecular Diagnostics: Market Landscape analyzes the emerging sector of molecular diagnostics. It provides a clear classification, assessing the leading technologies and key tests that are positioned in this exciting area of diagnostics. The current MDx market size and leading players are analyzed, with a market forecast of the MDx segment as well as the total in vitro diagnostic market over 2010-16 provided.

Table Of Contents

ABOUT DATAMONITIOR HEALTHCARE
About the PharmaVitae Company Analysis team

ABOUT THIS REPORT
Chapter structure
Classification of molecular diagnostics
Regulation and reimbursement of molecular diagnostics
The molecular diagnostics market

EXECUTIVE SUMMARY
Strategic scoping and focus
Datamonitor key findings

CLASSIFICATION OF MOLECULAR DIAGNOSTICS
Key findings
Datamonitor’s classification of molecular diagnostics
Level 1 classification
Level 2 classification
Level 3 classification
Level 4 classification
MDx subclassification
Key applications of pharmacogenetics – introducing "personalized medicine"

REGULATION AND REIMBURSEMENT OF MOLECULAR DIAGNOSTICS
Key findings
Regulatory landscape
The FDA operates a risk-based assessment
CLIA – regulation of clinical laboratories through the CMS
Four strategic routes to approval of a diagnostic test in the US
The EU: a more simplified approach – gaining the CE mark
The diagnostics market is much smaller than the prescription pharmaceutical market…
…although it can offer some attractions to investors
However, some hurdles exist
Challenges facing the molecular diagnostics industry: US reimbursement
Challenges facing the MDx industry: intellectual property

THE MOLECULAR DIAGNOSTICS MARKET
Key findings
Introduction
The global in vitro diagnostic and molecular diagnostic markets
Historical IVD and molecular diagnostic performance, 2004–10
Current market leaders: introduction to the key players
Forecast IVD and MDx performance, 2010–16
Overview of US-approved molecular diagnostics tests

APPENDIX
The key technologies
Table of US-approved/cleared molecular diagnostic tests
References
Exchange rates

Friday 9 December 2011

Epidemiology: Chronic Lower Back Pain – Millions will continue to be out of work over the next decade


Epidemiology: Chronic Lower Back Pain – Millions will continue to be out of work over the next decade - In 2010, Datamonitor estimates that there were about 55.7 million total prevalent cases of chronic low back pain in people aged 18 and over in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK). The majority of cases were in those aged between 40 and 59.
Features and benefits
• Gain insight into market potential, including a robust 10-year epidemiology forecast of chronic low back pain prevalent cases.
• Understand the key epidemiologic risk factors associated with chronic low back pain.

Table Of Contents
OVERVIEW

Catalyst
Summary

EXECUTIVE SUMMARY
Epidemiology of chronic low back pain
Chronic low back pain in the seven major markets
Datamonitor’s forecast of chronic low back pain

DISEASE DEFINITION AND DIAGNOSTIC CRITERIA
Low back pain background
Low back pain definition and classification

GLOBAL VARIATION AND HISTORICAL TRENDS
Low back pain is difficult to compare due to varying definitions
Low back pain causes significant morbidity but little mortality
Trends in chronic low back pain are unclear
Low back pain in children and adolescents
Prevalence is difficult to quantify due to varying definitions
Risk factors for low back pain in children and adolescents are similar to those in adults

Individual factors
Low back pain prevalence increases with age until peaking by around the age of 60
Gender is not significantly associated with low back pain
Smoking is related to an increased risk of low back pain
High body mass index and limited physical activity are associated with an increased risk of low back pain
Psychosocial factors determine severity of pain and reporting of symptoms
Occupational risk factors
Heavy lifting, twisting, and bending can significantly increase the likelihood of back pain
Sedentary work and consistent whole-body vibration raise the risk of low back pain
Causes associated with low back pain
Lumbar strain or sprain and fractures are the most common causes of back pain
Nerve irritation
Disc degeneration and herniation
Bony encroachment
Bone and joint conditions
Other



Wednesday 7 December 2011

Photonic Sensor Market (2011 - 2016) : Global Forecast - By Type (Laser, Biophotonic, Fiber Optic) & Application (Oil & Gas, Military & Aerospace, Energy & Infrastructure, Industrial Automation, Medical and Others)


Published: December 2011
No. of Pages: 159
Price: $ 4650
Photonic Sensor Market - The APAC region is expected to generate $2.61 billion with a CAGR of 21.31%; followed by Europe, North America, and ROW at a CAGR of 14.56%, 13.56%, and 12.94% respectively from 2011 to 2016. Among the APAC countries, China is expected to be the biggest emerging market for photonic sensors.

Photonic sensing technology incorporates emission of light, transmission, deflection, amplification and detection by optical components, instruments, lasers, other light sources, fiber optics, electro-optical instrumentation, and sophisticated nanophotonic systems. It provides smaller, cheaper, lighter and faster components and products, with greater functionality while using less energy.

In recent years, photonics has been recognized as an enabling technology that impacts, extends across, and underpins a whole host of industrial sectors, from healthcare to security, from manufacturing to telecommunications, from energy to the environment, and from aerospace to biotechnology. In all these sectors, photonics sensing activity can be recognized via the intelligent application of light (‘optical radiation’) either in an entirely novel context such as a new photodynamic medical treatment, or as a replacement for an older outdated technology such as signage and lighting based on the use of incandescent lamps. 


Photonic sensors are now key technologies in oil and gas exploration in European market, due to which it is the second fastest growing market after APAC region.

A market in industrial category requires global commercialization for it to generate constant revenues for the major players. Currently, photonic sensors face a major challenge in product compatibility and shortage of skilled and trained personnel who lack the required technical expertise to adapt to the latest technology. From an end-user perspective, it is important to recognize that no matter how good the sensor is, there needs to be some level of incorporation into a system, often an instrument, for it to actually fill an economically useful note.

Regarding laser sensors, European market is expected to be slow and reluctant in the next five years; Asia is a strong market whereas U.S. is faced by many highs and lows mainly due to unstable customer preferences and regularly changing technologies


Monday 5 December 2011

Health on the Restaurant Menu: Foodservice Trends in the U.S.


Published: December 2011
No. of Pages: 122
Price: $ 3995


Health on the Restaurant Menu: Foodservice Trends in the U.S. helps foodservice industry participants align their branding and menu development strategies with evolving consumer health perceptions and expectations; the quickly evolving health education landscape; and the effects of nationwide menu regulation.

Browse All: Food Market Research Reports

The report does the following:

1. Identifies drivers and trends that have helped cause the industry to reflect on its role in addressing America's health.

This helps participants better understand new menu regulations and menu item trends.
2. Analyses health-related menu trends, including salt and added sugar reduction; healthy menu claim trend analysis; "mini" menu item trend analysis; fruit and vegetable menu trend analysis; and health & anti-health menu analysis of specific restaurants.
This helps participants stay on top of menu development.
3. Draws from a variety of industry and academic research to help the restaurant industry gauge the effect and result of menu labeling legislation.
This helps participants frame the impact of menu regulation on industry segments, major chains, and independent restaurant operators.
4. Analyses consumer attitudes toward diet food and health from the perspectives of their healthful propensities; not-so-healthful propensities; and knowledge, money & time.
This helps participants understand shifting consumer health & wellness propensities and respond accordingly.
5. Creates and analyzes four consumer groups, each of which share common health-driven characteristics: Health First, Health Maintainers, Health Endorsers and Carefree Eaters. Each group isolates populations having distinct degrees of food health interest and distinct degrees of restaurant interaction. Data on restaurant frequency, brand usage, and presence of children are included.
This helps industry participants target groups according to their healthful propensities, as well as to their restaurant loyalty, the effect of their having children, and their brand usage.
6. Studies the degree of importance restaurant goers ascribe to various food health attributes as applied to two distinct dining occasions: getting food for a "quick bite" and getting food for a "special occasion."
This helps participants shape health-driven strategies around occasions for use.
Coverage includes snack and beverage restaurant concepts, limited-service restaurants (QSR and fast casual), and full-service restaurants (family, casual and fine dining).


Natural and Organic Personal Care Products in the U.S., 5th Edition


Published: December 2011
No. of Pages: 294
Price: $ 3750
U.S. Natural Personal Care Market - In 2011, the business world takes for granted that sales of natural health & beauty care (HBC) brands will keep on thriving; this is no longer news. Packaged Facts forecasts that the U.S. consumer market for natural and organic skincare, haircare, and makeup-which during 2005-2010 boomed 61% to $7.7 billion-could top $11.0 billion as of 2016. Already, natural HBC is such a solid performer, that it can be considered a component of the mainstream personal care market: Many of the players have finally learned that their moisturizer, shampoo, or eye shadow must be packaged as slickly as non-natural versions. And "green" consumers are more receptive, too, even to the point of remaining loyal to natural HBC brands in the recession of 2008-2009. But what comes next? In the coming years, the battleground will be complicated by the Big Blur of retail channels; by new digital sell-through media; by reformulations to please mainstream America; and by changing world economics that will start to reverse the generations-old flow of U.S. brands to developing countries. The opportunities get hotter and hotter... But is it time to begin looking for the cracks?

Packaged Facts' newest edition of our best-selling guide to the natural HBC market portrays its molten dynamics. Separate chapters on skincare, haircare, and makeup contain historical and future dollar patterns, together with Packaged Facts' famous in-depth analysis. Extensive demographic data from Packaged Facts' own February 2011 consumer survey are also included. Plus the battle profiles of Better Botanicals, Clorox/Burt's Bees, Estee Lauder/Aveda, Hain Celestial, Weleda, and others are detailed.

Report Methodology
Natural and Organic Personal Care Products in the U.S., 5th Edition is based on information gathered from primary, secondary, and syndicated sources. Primary research involves on-site study of how natural HBC products are sold through retail stores; Packaged Facts also consults with industry executives. Secondary research involves the evaluation and comparison of data from mountains of articles found in financial, marketing, and retail publications, as well as on corresponding types of websites. Company literature, government agencies, and other sources also provide valuable secondary data.

Stats on market revenues and growth trends derive from all available data on the consumer natural personal care marketplace, be they quantitative or qualitative; that is to say, a broad range of societal and economic trends are factored in, to help shape the most accurate possible view of sales progress.


Sunday 4 December 2011

Lawn and Garden Products & Services in the U.S., 9th Edition



Published: December 2011
No. of Pages: 212
Price: $ 3750


This new edition continues Packaged Facts' tradition of comprehensive coverage of the U.S. lawn & garden market, valued at over $25 billion at retail in 2011. Closely linked to housing and employment trends, the market has suffered from the recession and its lingering drag on the economy, as well as other dampening factors including high energy prices and climate concerns. Some of those challenges also represent opportunities, however. For example, "green" gardening threatens traditional L&G (gas-powered machinery, synthetic chemicals), but also offers a way forward into a more sustainable future as a new generation of gardeners embrace trends including organic gardening and food gardening. The all-important aging Boomer segment also holds promise, including in professional lawn care services.

Browse All: Consumer Goods Market Research

Building on the continuity and coverage of previous editions, this fully updated report examines the U.S. market for lawn and garden products and services, including all products and services sold for maintenance, treatment, and enhancement of lawns, gardens, and landscapes. Focusing primarily on the consumer sector, the report Lawn and Garden Products & Services in the U.S., 9th Edition divides the market into three categories: Equipment (power and hand-held), Supplies (insecticides and fertilizer), and Services. Following an overview chapter detailing the market as a whole and providing cross-category perspective, the study offers separate in-depth chapter analyses of each category, including market size, composition, and projections; competitive trends; retail trends; and consumer trends.

An important new feature is consumer data from Packaged Facts' proprietary online survey conducted in September 2011, supplemented by cross-tabulated consumer survey results from Experian Simmons. Coverage includes trended levels of participation in home gardening and trended ownership and purchasing rates for three categories: power equipment, hand held tools, and supplies. Each of these categories is broken down by product type, with proprietary survey data indicating level of spending and outlet for purchasing. The report also presents demographic profiles and highlights of the U.S. gardener and of participants in each of the product categories, and quantifies consumer usage rates and spending trends for professional lawn care services.